237 related articles for article (PubMed ID: 9771389)
1. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.
Miura M; Morris GM; Micca PL; Nawrocky MM; Makar MS; Cook SP; Slatkin DN
Br J Radiol; 2004 Jul; 77(919):573-80. PubMed ID: 15238404
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyldeuteroporphyrin IX in mice.
Miura M; Micca PL; Heinrichs JC; Gabel D; Fairchild RG; Slatkin DN
Biochem Pharmacol; 1992 Feb; 43(3):467-76. PubMed ID: 1540204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing mice.
Miura M; Micca PL; Fisher CD; Heinrichs JC; Donaldson JA; Finkel GC; Slatkin DN
Int J Cancer; 1996 Sep; 68(1):114-9. PubMed ID: 8895550
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin.
Miura M; Morris GM; Micca PL; Lombardo DT; Youngs KM; Kalef-Ezra JA; Hoch DA; Slatkin DN; Ma R; Coderre JA
Radiat Res; 2001 Apr; 155(4):603-10. PubMed ID: 11260662
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
8. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
9. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
10. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
11. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
Wu H; Micca PL; Makar MS; Miura M
Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
[TBL] [Abstract][Full Text] [Related]
15. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
19. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
